Pre-order Enquiry
Request Free Sample
Global Duchenne Muscular Dystrophy Market Research Report 2020
SKU ID : QYR-15069126 | Publishing Date : 10-Jan-2020 | No. of pages : 98
Detailed TOC of Global Duchenne Muscular Dystrophy Market Research Report 2020
Table of Contents1 Duchenne Muscular Dystrophy Market Overview
1.1 Product Overview and Scope of Duchenne Muscular Dystrophy
1.2 Duchenne Muscular Dystrophy Segment by Type
1.2.1 Global Duchenne Muscular Dystrophy Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Deflazacort
1.2.3 Prednisone
1.2.4 Others
1.3 Duchenne Muscular Dystrophy Segment by Application
1.3.1 Duchenne Muscular Dystrophy Sales Comparison by Application: 2020 VS 2026
1.3.2 Male
1.3.3 Female
1.4 Global Duchenne Muscular Dystrophy Market Size Estimates and Forecasts
1.4.1 Global Duchenne Muscular Dystrophy Revenue 2015-2026
1.4.2 Global Duchenne Muscular Dystrophy Sales 2015-2026
1.4.3 Duchenne Muscular Dystrophy Market Size by Region: 2020 Versus 2026
2 Global Duchenne Muscular Dystrophy Market Competition by Manufacturers
2.1 Global Duchenne Muscular Dystrophy Sales Market Share by Manufacturers (2015-2020)
2.2 Global Duchenne Muscular Dystrophy Revenue Share by Manufacturers (2015-2020)
2.3 Global Duchenne Muscular Dystrophy Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Duchenne Muscular Dystrophy Manufacturing Sites, Area Served, Product Type
2.5 Duchenne Muscular Dystrophy Market Competitive Situation and Trends
2.5.1 Duchenne Muscular Dystrophy Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Duchenne Muscular Dystrophy Players (Opinion Leaders)
3 Duchenne Muscular Dystrophy Retrospective Market Scenario by Region
3.1 Global Duchenne Muscular Dystrophy Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Duchenne Muscular Dystrophy Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Duchenne Muscular Dystrophy Market Facts & Figures by Country
3.3.1 North America Duchenne Muscular Dystrophy Sales by Country
3.3.2 North America Duchenne Muscular Dystrophy Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Duchenne Muscular Dystrophy Market Facts & Figures by Country
3.4.1 Europe Duchenne Muscular Dystrophy Sales by Country
3.4.2 Europe Duchenne Muscular Dystrophy Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Duchenne Muscular Dystrophy Market Facts & Figures by Region
3.5.1 Asia Pacific Duchenne Muscular Dystrophy Sales by Region
3.5.2 Asia Pacific Duchenne Muscular Dystrophy Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Duchenne Muscular Dystrophy Market Facts & Figures by Country
3.6.1 Latin America Duchenne Muscular Dystrophy Sales by Country
3.6.2 Latin America Duchenne Muscular Dystrophy Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Duchenne Muscular Dystrophy Market Facts & Figures by Country
3.7.1 Middle East and Africa Duchenne Muscular Dystrophy Sales by Country
3.7.2 Middle East and Africa Duchenne Muscular Dystrophy Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Duchenne Muscular Dystrophy Historic Market Analysis by Type
4.1 Global Duchenne Muscular Dystrophy Sales Market Share by Type (2015-2020)
4.2 Global Duchenne Muscular Dystrophy Revenue Market Share by Type (2015-2020)
4.3 Global Duchenne Muscular Dystrophy Price Market Share by Type (2015-2020)
4.4 Global Duchenne Muscular Dystrophy Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Duchenne Muscular Dystrophy Historic Market Analysis by Application
5.1 Global Duchenne Muscular Dystrophy Sales Market Share by Application (2015-2020)
5.2 Global Duchenne Muscular Dystrophy Revenue Market Share by Application (2015-2020)
5.3 Global Duchenne Muscular Dystrophy Price by Application (2015-2020)
6 Company Profiles and Key Figures in Duchenne Muscular Dystrophy Business
6.1 PTC Therapeutics
6.1.1 Corporation Information
6.1.2 PTC Therapeutics Description, Business Overview and Total Revenue
6.1.3 PTC Therapeutics Duchenne Muscular Dystrophy Sales, Revenue and Gross Margin (2015-2020)
6.1.4 PTC Therapeutics Products Offered
6.1.5 PTC Therapeutics Recent Development
6.2 Sarepta Therapeutics
6.2.1 Sarepta Therapeutics Duchenne Muscular Dystrophy Production Sites and Area Served
6.2.2 Sarepta Therapeutics Description, Business Overview and Total Revenue
6.2.3 Sarepta Therapeutics Duchenne Muscular Dystrophy Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Sarepta Therapeutics Products Offered
6.2.5 Sarepta Therapeutics Recent Development
6.3 Others
6.3.1 Others Duchenne Muscular Dystrophy Production Sites and Area Served
6.3.2 Others Description, Business Overview and Total Revenue
6.3.3 Others Duchenne Muscular Dystrophy Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Others Products Offered
6.3.5 Others Recent Development
7 Duchenne Muscular Dystrophy Manufacturing Cost Analysis
7.1 Duchenne Muscular Dystrophy Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Duchenne Muscular Dystrophy
7.4 Duchenne Muscular Dystrophy Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Duchenne Muscular Dystrophy Distributors List
8.3 Duchenne Muscular Dystrophy Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Duchenne Muscular Dystrophy Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Duchenne Muscular Dystrophy by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Duchenne Muscular Dystrophy by Type (2021-2026)
10.2 Duchenne Muscular Dystrophy Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Duchenne Muscular Dystrophy by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Duchenne Muscular Dystrophy by Application (2021-2026)
10.3 Duchenne Muscular Dystrophy Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Duchenne Muscular Dystrophy by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Duchenne Muscular Dystrophy by Region (2021-2026)
10.4 North America Duchenne Muscular Dystrophy Estimates and Projections (2021-2026)
10.5 Europe Duchenne Muscular Dystrophy Estimates and Projections (2021-2026)
10.6 Asia Pacific Duchenne Muscular Dystrophy Estimates and Projections (2021-2026)
10.7 Latin America Duchenne Muscular Dystrophy Estimates and Projections (2021-2026)
10.8 Middle East and Africa Duchenne Muscular Dystrophy Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Figures, Tables and Charts Available in Global Duchenne Muscular Dystrophy Market Research Report 2020
List of TablesTable 1. Global Duchenne Muscular Dystrophy Sales (K Doses) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Duchenne Muscular Dystrophy Sales (K Doses) Comparison by Application: 2020 VS 2026
Table 3. Global Duchenne Muscular Dystrophy Market Size by Type (K Doses) (US$ Million) (2020 VS 2026)
Table 4. Global Key Duchenne Muscular Dystrophy Manufacturers Covered in This Study
Table 5. Global Duchenne Muscular Dystrophy Sales (K Doses) by Manufacturers (2015-2020)
Table 6. Global Duchenne Muscular Dystrophy Sales Share by Manufacturers (2015-2020)
Table 7. Global Duchenne Muscular Dystrophy Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Duchenne Muscular Dystrophy Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Duchenne Muscular Dystrophy Average Price (USD/Dose) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Duchenne Muscular Dystrophy Sales Sites and Area Served
Table 11. Manufacturers Duchenne Muscular Dystrophy Product Types
Table 12. Global Duchenne Muscular Dystrophy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Duchenne Muscular Dystrophy by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Duchenne Muscular Dystrophy as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Duchenne Muscular Dystrophy Players
Table 16. Global Duchenne Muscular Dystrophy Sales (K Doses) by Region (2015-2020)
Table 17. Global Duchenne Muscular Dystrophy Sales Market Share by Region (2015-2020)
Table 18. Global Duchenne Muscular Dystrophy Revenue (Million US$) by Region (2015-2020)
Table 19. Global Duchenne Muscular Dystrophy Revenue Market Share by Region (2015-2020)
Table 20. North America Duchenne Muscular Dystrophy Sales by Country (2015-2020) (K Doses)
Table 21. North America Duchenne Muscular Dystrophy Sales Market Share by Country (2015-2020)
Table 22. North America Duchenne Muscular Dystrophy Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Duchenne Muscular Dystrophy Revenue Market Share by Country (2015-2020)
Table 24. Europe Duchenne Muscular Dystrophy Sales by Country (2015-2020) (K Doses)
Table 25. Europe Duchenne Muscular Dystrophy Sales Market Share by Country (2015-2020)
Table 26. Europe Duchenne Muscular Dystrophy Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Duchenne Muscular Dystrophy Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Duchenne Muscular Dystrophy Sales by Region (2015-2020) (K Doses)
Table 29. Asia Pacific Duchenne Muscular Dystrophy Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Duchenne Muscular Dystrophy Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Duchenne Muscular Dystrophy Revenue Market Share by Region (2015-2020)
Table 32. Latin America Duchenne Muscular Dystrophy Sales by Country (2015-2020) (K Doses)
Table 33. Latin America Duchenne Muscular Dystrophy Sales Market Share by Country (2015-2020)
Table 34. Latin America Duchenne Muscular Dystrophy Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Duchenne Muscular Dystrophy Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Duchenne Muscular Dystrophy Sales by Country (2015-2020) (K Doses)
Table 37. Middle East and Africa Duchenne Muscular Dystrophy Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Duchenne Muscular Dystrophy Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Duchenne Muscular Dystrophy Revenue Market Share by Country (2015-2020)
Table 40. Global Duchenne Muscular Dystrophy Sales (K Doses) by Type (2015-2020)
Table 41. Global Duchenne Muscular Dystrophy Sales Share by Type (2015-2020)
Table 42. Global Duchenne Muscular Dystrophy Revenue (Million US$) by Type (2015-2020)
Table 43. Global Duchenne Muscular Dystrophy Revenue Share by Type (2015-2020)
Table 44. Global Duchenne Muscular Dystrophy Price (USD/Dose) by Type (2015-2020)
Table 45. Global Duchenne Muscular Dystrophy Sales (K Doses) by Application (2015-2020)
Table 46. Global Duchenne Muscular Dystrophy Sales Market Share by Application (2015-2020)
Table 47. Global Duchenne Muscular Dystrophy Sales Growth Rate by Application (2015-2020)
Table 48. PTC Therapeutics Duchenne Muscular Dystrophy Corporation Information
Table 49. PTC Therapeutics Description and Business Overview
Table 50. PTC Therapeutics Duchenne Muscular Dystrophy Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 51. PTC Therapeutics Main Product
Table 52. PTC Therapeutics Recent Development
Table 53. Sarepta Therapeutics Duchenne Muscular Dystrophy Corporation Information
Table 54. Sarepta Therapeutics Corporation Information
Table 55. Sarepta Therapeutics Duchenne Muscular Dystrophy Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 56. Sarepta Therapeutics Main Product
Table 57. Sarepta Therapeutics Recent Development
Table 58. Others Duchenne Muscular Dystrophy Corporation Information
Table 59. Others Corporation Information
Table 60. Others Duchenne Muscular Dystrophy Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 61. Others Main Product
Table 62. Others Recent Development
Table 63. Sales Base and Market Concentration Rate of Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Duchenne Muscular Dystrophy Distributors List
Table 66. Duchenne Muscular Dystrophy Customers List
Table 67. Market Key Trends
Table 68. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 69. Key Challenges
Table 70. Global Duchenne Muscular Dystrophy Sales (K Doses) Forecast by Type (2021-2026)
Table 71. Global Duchenne Muscular Dystrophy Sales Market Share Forecast by Type (2021-2026)
Table 72. Global Duchenne Muscular Dystrophy Revenue (Million US$) Forecast by Type (2021-2026)
Table 73. Global Duchenne Muscular Dystrophy Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 74. Global Duchenne Muscular Dystrophy Sales (K Doses) Forecast by Application (2021-2026)
Table 75. Global Duchenne Muscular Dystrophy Revenue (Million US$) Forecast by Application (2021-2026)
Table 76. Global Duchenne Muscular Dystrophy Sales (K Doses) Forecast by Region (2021-2026)
Table 77. Global Duchenne Muscular Dystrophy Sales Market Share Forecast by Region (2021-2026)
Table 78. Global Duchenne Muscular Dystrophy Revenue Forecast by Region (2021-2026) (US$ Million)
Table 79. Global Duchenne Muscular Dystrophy Revenue Market Share Forecast by Region (2021-2026)
Table 80. Research Programs/Design for This Report
Table 81. Key Data Information from Secondary Sources
Table 82. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Duchenne Muscular Dystrophy
Figure 2. Global Duchenne Muscular Dystrophy Sales Market Share by Type: 2020 VS 2026
Figure 3. Deflazacort Product Picture
Figure 4. Prednisone Product Picture
Figure 5. Others Product Picture
Figure 6. Global Duchenne Muscular Dystrophy Consumption Market Share by Application: 2020 VS 2026
Figure 7. Male
Figure 8. Female
Figure 9. Global Duchenne Muscular Dystrophy Market Size 2015-2026 (US$ Million)
Figure 10. Global Duchenne Muscular Dystrophy Sales Capacity (K Doses) (2015-2026)
Figure 11. Global Duchenne Muscular Dystrophy Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Duchenne Muscular Dystrophy Sales Share by Manufacturers in 2020
Figure 13. Global Duchenne Muscular Dystrophy Revenue Share by Manufacturers in 2019
Figure 14. The Global 5 and 10 Largest Players: Market Share by Duchenne Muscular Dystrophy Revenue in 2019
Figure 15. Duchenne Muscular Dystrophy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 16. Global Duchenne Muscular Dystrophy Sales Market Share by Region (2015-2020)
Figure 17. Global Duchenne Muscular Dystrophy Sales Market Share by Region in 2019
Figure 18. Global Duchenne Muscular Dystrophy Revenue Market Share by Region (2015-2020)
Figure 19. Global Duchenne Muscular Dystrophy Revenue Market Share by Region in 2019
Figure 20. North America Duchenne Muscular Dystrophy Sales Market Share by Country in 2019
Figure 21. North America Duchenne Muscular Dystrophy Revenue Market Share by Country in 2019
Figure 22. U.S. Duchenne Muscular Dystrophy Sales Growth Rate (2015-2020) (K Doses)
Figure 23. U.S. Duchenne Muscular Dystrophy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 24. Canada Duchenne Muscular Dystrophy Sales Growth Rate (2015-2020) (K Doses)
Figure 25. Canada Duchenne Muscular Dystrophy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Europe Duchenne Muscular Dystrophy Sales Market Share by Country in 2019
Figure 27. Europe Duchenne Muscular Dystrophy Revenue Market Share by Country in 2019
Figure 28. Germany Duchenne Muscular Dystrophy Sales Growth Rate (2015-2020) (K Doses)
Figure 29. Germany Duchenne Muscular Dystrophy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 30. France Duchenne Muscular Dystrophy Sales Growth Rate (2015-2020) (K Doses)
Figure 31. France Duchenne Muscular Dystrophy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. U.K. Duchenne Muscular Dystrophy Sales Growth Rate (2015-2020) (K Doses)
Figure 33. U.K. Duchenne Muscular Dystrophy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Italy Duchenne Muscular Dystrophy Sales Growth Rate (2015-2020) (K Doses)
Figure 35. Italy Duchenne Muscular Dystrophy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Russia Duchenne Muscular Dystrophy Sales Growth Rate (2015-2020) (K Doses)
Figure 37. Russia Duchenne Muscular Dystrophy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Asia Pacific Duchenne Muscular Dystrophy Sales Market Share by Region in 2019
Figure 39. Asia Pacific Duchenne Muscular Dystrophy Revenue Market Share by Region in 2019
Figure 40. China Duchenne Muscular Dystrophy Sales Growth Rate (2015-2020) (K Doses)
Figure 41. China Duchenne Muscular Dystrophy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Japan Duchenne Muscular Dystrophy Sales Growth Rate (2015-2020) (K Doses)
Figure 43. Japan Duchenne Muscular Dystrophy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. South Korea Duchenne Muscular Dystrophy Sales Growth Rate (2015-2020) (K Doses)
Figure 45. South Korea Duchenne Muscular Dystrophy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. India Duchenne Muscular Dystrophy Sales Growth Rate (2015-2020) (K Doses)
Figure 47. India Duchenne Muscular Dystrophy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Australia Duchenne Muscular Dystrophy Sales Growth Rate (2015-2020) (K Doses)
Figure 49. Australia Duchenne Muscular Dystrophy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Taiwan Duchenne Muscular Dystrophy Sales Growth Rate (2015-2020) (K Doses)
Figure 51. Taiwan Duchenne Muscular Dystrophy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Indonesia Duchenne Muscular Dystrophy Sales Growth Rate (2015-2020) (K Doses)
Figure 53. Indonesia Duchenne Muscular Dystrophy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Thailand Duchenne Muscular Dystrophy Sales Growth Rate (2015-2020) (K Doses)
Figure 55. Thailand Duchenne Muscular Dystrophy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Malaysia Duchenne Muscular Dystrophy Sales Growth Rate (2015-2020) (K Doses)
Figure 57. Malaysia Duchenne Muscular Dystrophy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Philippines Duchenne Muscular Dystrophy Sales Growth Rate (2015-2020) (K Doses)
Figure 59. Philippines Duchenne Muscular Dystrophy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Vietnam Duchenne Muscular Dystrophy Sales Growth Rate (2015-2020) (K Doses)
Figure 61. Vietnam Duchenne Muscular Dystrophy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Latin America Duchenne Muscular Dystrophy Sales Market Share by Country in 2019
Figure 63. Latin America Duchenne Muscular Dystrophy Revenue Market Share by Country in 2019
Figure 64. Mexico Duchenne Muscular Dystrophy Sales Growth Rate (2015-2020) (K Doses)
Figure 65. Mexico Duchenne Muscular Dystrophy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Brazil Duchenne Muscular Dystrophy Sales Growth Rate (2015-2020) (K Doses)
Figure 67. Brazil Duchenne Muscular Dystrophy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Argentina Duchenne Muscular Dystrophy Sales Growth Rate (2015-2020) (K Doses)
Figure 69. Argentina Duchenne Muscular Dystrophy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Middle East and Africa Duchenne Muscular Dystrophy Sales Market Share by Country in 2019
Figure 71. Middle East and Africa Duchenne Muscular Dystrophy Revenue Market Share by Country in 2019
Figure 72. Turkey Duchenne Muscular Dystrophy Sales Growth Rate (2015-2020) (K Doses)
Figure 73. Turkey Duchenne Muscular Dystrophy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Saudi Arabia Duchenne Muscular Dystrophy Sales Growth Rate (2015-2020) (K Doses)
Figure 75. Saudi Arabia Duchenne Muscular Dystrophy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. U.A.E Duchenne Muscular Dystrophy Sales Growth Rate (2015-2020) (K Doses)
Figure 77. U.A.E Duchenne Muscular Dystrophy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Sales Market Share of Duchenne Muscular Dystrophy by Type (2015-2020)
Figure 79. Sales Market Share of Duchenne Muscular Dystrophy by Type in 2019
Figure 80. Revenue Share of Duchenne Muscular Dystrophy by Type (2015-2020)
Figure 81. Revenue Market Share of Duchenne Muscular Dystrophy by Type in 2019
Figure 82. Global Duchenne Muscular Dystrophy Sales Growth by Type (2015-2020) (K Doses)
Figure 83. Global Duchenne Muscular Dystrophy Sales Market Share by Application (2015-2020)
Figure 84. Global Duchenne Muscular Dystrophy Sales Market Share by Application in 2019
Figure 85. Global Revenue Share of Duchenne Muscular Dystrophy by Application (2015-2020)
Figure 86. Global Revenue Share of Duchenne Muscular Dystrophy by Application in 2020
Figure 87. PTC Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Sarepta Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Others Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Price Trend of Key Raw Materials
Figure 91. Manufacturing Cost Structure of Duchenne Muscular Dystrophy
Figure 92. Manufacturing Process Analysis of Duchenne Muscular Dystrophy
Figure 93. Duchenne Muscular Dystrophy Industrial Chain Analysis
Figure 94. Channels of Distribution
Figure 95. Distributors Profiles
Figure 96. Porter's Five Forces Analysis
Figure 97. North America Duchenne Muscular Dystrophy Sales (K Doses) and Growth Rate Forecast (2021-2026)
Figure 98. North America Duchenne Muscular Dystrophy Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 99. Europe Duchenne Muscular Dystrophy Sales (K Doses) and Growth Rate Forecast (2021-2026)
Figure 100. Europe Duchenne Muscular Dystrophy Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 101. Latin America Duchenne Muscular Dystrophy Sales (K Doses) and Growth Rate Forecast (2021-2026)
Figure 102. Latin America Duchenne Muscular Dystrophy Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 103. Middle East and Africa Duchenne Muscular Dystrophy Sales (K Doses) and Growth Rate Forecast (2021-2026)
Figure 104. Middle East and Africa Duchenne Muscular Dystrophy Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 105. Asia Pacific Duchenne Muscular Dystrophy Sales (K Doses) and Growth Rate Forecast (2021-2026)
Figure 106. Asia Pacific Duchenne Muscular Dystrophy Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 107. Bottom-up and Top-down Approaches for This Report
Figure 108. Data Triangulation
Figure 109. Key Executives Interviewed
Keyplayers in Global Duchenne Muscular Dystrophy Market Research Report 2020
PTC TherapeuticsSarepta Therapeutics
Others
Request Sample
Request Discount
